Since starting in the UK in 1947 with just 38,000 members BUPA has developed into an internationally respected international health insurance and healthcare group with over 33 million customers worldwide and over 80,000 employees.
Bupa will cover:
- medical expenses,
- medical evacuation and medical repatriation related to COVID-19 diagnosis on an ex gratia basis.
Expenses covered will be the cost of COVID-19 testing (excluding antibody testing) where this is prescribed by a medical professional as well as costs related to treatment, medication or hospitalisation resulting from having contracted COVID-19 provided such procedures have been prescribed by a medical professional.
Exceptions to cover will be:
testing for visa purposes
testing to comply with mandatory or recommended testing prior to travelling, upon arrival or during the trip unless you exhibit COVID-19 symptoms and such testing has been prescribed by a medical professional.
testing as part of mandatory or recommended quarantine unless you exhibit COVID-19 symptoms and such testing is prescribed by a medical professional
NOTE: Medical evacuation and medical repatriation of COVID-19 patients must be conducted in full compliance with standard policy conditions, including the requirement for Bupa Global Travel’s medical consultant to agree on the necessity of transferring the patient. Please also note that medical evacuation of a COVID-19 patient may be subject to local restrictions.
Company History
Bupa Global was established in 1971 as the international health insurance division of Bupa and fiver years later, Bupa Asia Ltd was established in Hong Kong.
Bupa Global now has offices in London and Brighton (UK), Miami (USA), Copenhagen (Denmark), Dubai (UAE, in partnership with OIC), and Hong Kong (China) as well as regional offices in mainland China, Singapore, Egypt, Mexico, the Dominican Republic, Bolivia, Brazil, Panama, Guatemala and Ecuador.
Company’s Annual Report
Insurance from Bupa Global
Health Insurance: International Health and Hospital Plan